0001104659-24-001373.txt : 20240104
0001104659-24-001373.hdr.sgml : 20240104
20240104162450
ACCESSION NUMBER: 0001104659-24-001373
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LUCI DAVID P
CENTRAL INDEX KEY: 0001271123
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40536
FILM NUMBER: 24512277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001736243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
BUSINESS PHONE: 917-533-1469
MAIL ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
FORMER COMPANY:
FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20180402
4
1
tm242052-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-03
0
0001736243
Acurx Pharmaceuticals, Inc.
ACXP
0001271123
LUCI DAVID P
C/O ACURX PHARMACEUTICALS, INC.,
259 LIBERTY AVENUE
STATEN ISLAND
NY
10305
1
1
1
0
President and CEO
0
Common Stock
2024-01-03
4
M
0
19737
3.55
A
1048197
D
Common Stock
15083
I
By spouse
Common Stock
35000
I
By child
Warrants for Common Stock
3.55
2024-01-03
4
M
0
19737
0
D
2023-01-27
2024-01-27
Common Stock
19737
0
D
/s/ David P. Luci
2024-01-04